Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia

Tyrosine kinase inhibitor treatment of chronic myeloid leukemia (CML) has demonstrated beneficial effects. However, resistance to tyrosine kinase inhibitors and disease relapse are still a challenge for CML therapy. In this study, we analyzed bone marrow samples from 149 CML patients and 15 control...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cell Death Dis
Main Authors: Li, Wei, Ji, Min, Lu, Fei, Pang, Yihua, Dong, Xin, Zhang, Jingru, Li, Peng, Ye, Jingjing, Zang, Shaolei, Ma, Daoxin, Ji, Chunyan
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group UK 2018
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6113287/
https://ncbi.nlm.nih.gov/pubmed/30154435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-0900-7
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker